MDHearing Volt vs Signia Pure Charge&Go MaX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

MDHearing Volt
The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.
Choice

Signia Pure Charge&Go MaX
The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit